| class=”lh”> plans By Catherine Galioto and Patricia A. Miller, a local boy working families in order to increase its support to its type 1 administration diabetes , by adding an “ diabetes Dog Awareness” of the family. A series of local fundraisers will help the money …
|
| class=”lh”> |
04
Feb 2012
| Zap2it.com (blog) |
class=”lh”> / b> Q: I have been diagnosed with type 2 diabetes and I am very confused insulin resistance, and what I can and carbohydrates can not eat. So much of what I read is contradictory. A: The first line of defense against type 2 diabetes is weight loss, … Diabetics fiasco and sugar intake diabetes drug: Should celebrities be in favor of pharmaceutical – – class = “p”
|
03
Feb 2012
 PR Web (press release) |
Distinguish Type 1 From Type 2 Diabetes in Obese Youth
Family Practice News Digital Network (EGMN) – New-onset type 1 diabetes in an obese youth cannot reliably be distinguished from pediatric type 2 diabetes on clinical grounds in this era of epidemic obesity. "The only way to distinguish obese type 1 diabetes from type 2 diabetes is to … Phoenix Diabetes Lifestyle Coach and Endocrinologist Host Free, Informative … Over the Counter: Live healthier now and later According to Recent Studies 26 Million Americans are Living with Diabetes and … |
|
FDA Okays Merck's Janumet XR For Type 2 Diabetes – Update
RTT News Inc. (MRK: News ) said Thursday the US Food and Drug Administration has approved its Janumet XR tablets as a new treatment for type 2 diabetes. The drug will be available in US pharmacies in the next several weeks. Janumet XR combines sitagliptin, … FDA Approves JANUMET(R) XR (sitagliptin and metformin HCl extended-release … Merck wins approval for extended release Janumet FDA Approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for … |
02
Feb 2012
| Family Practice News Digital Network |
style = class=”lh”> Treatment disappointed in Study 1 (HealthDay News) – were able> to handle the latest study with a drug called GAD-alum for type 1 diabetes … Diabetes size =
|
|
Combination Type 2 Diabetes Pill Gets FDA Nod
Medscape January 31, 2012 — The US Food and Drug Administration (FDA) today approved a combination pill containing the dipeptidyl peptidase-4 inhibitor linagliptin and metformin hydrochloride for the treatment of adults with type 2 diabetes. CORRECT(1/30): FDA Approves Eli Lilly Diabetes Combo Drug Jentadueto FDA Approves Linagliptin/Metformin Combo For Type 2 Diabetes FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for … |
 LifeHealthPro |
Weekly shot gets FDA nod for Type 2 diabetes
CBS News The FDA has given its nod to Bydureon, making it the first weekly treatment for type 2 diabetes, according to drug's manufacturer. Given as a shot, Bydureon (pronounced by-DUR-ee-on) is the long-acting form of Byetta, a twice-daily injection. Amylin's long-delayed diabetes drug gets FDA nod Amylin Shares Rise on Diabetes Drug Approval, Challenges Loom FDA approves exenatide extended-release for injectable suspension in type 2 … |
30
Jan 2012
| class=”lh”> 2 diabetes can be avoided There are sweet choices for the 79 million adult Americans with prediabetes – a condition that the blood sugar level is too high, make to be healthy, but not high enough to qualify for adult diabetes . Walking 30 minutes a day, five days a week (we had …
|